Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
about
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersTWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancerEvaluation of cytokeratin-19 in breast cancer tissue samples: a comparison of automatic and manual evaluations of scanned tissue microarray cylinders.Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer.Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome.Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas.Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients.Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.Use of Microarrays as a High-Throughput Platform for Label-Free Biosensing.Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry.Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains.A next-generation tissue microarray (ngTMA) protocol for biomarker studies.Tissue Microarray Technology for Molecular Applications: Investigation of Cross-Contamination between Tissue Samples Obtained from the Same Punching Device.Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer.Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer.The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.Larger core size has superior technical and analytical accuracy in bladder tissue microarray.Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases.Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases.TERT Promoter Mutations but not the Alternative Lengthening of Telomeres Phenotype Are Present in a Subset of Ependymomas and Are Associated With Adult Onset and Progression to Ependymosarcoma.Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.Expression Analysis of Autophagy Related Markers LC3B, p62 and HMGB1 Indicate an Autophagy-Independent Negative Prognostic Impact of High p62 Expression in Pulmonary Squamous Cell Carcinomas
P2860
Q35151124-C9F7D3AB-53C3-4D35-9AE1-E55C5D246329Q35176169-6C9FB805-BBCD-403C-95D5-0B8B85E41862Q35989561-128BDDFE-DFE0-4B9E-A347-917251FD6101Q36001921-37DB5ACD-F23C-4E6B-83BF-3B42F6FC649DQ36821128-D95CD8DE-0094-4046-AA10-4BC39CFE5CF9Q37457478-12AB310E-20C9-428F-962E-D63C727077FAQ37601727-7337A79D-C8F2-443D-BA3E-B3FC75BE1FB8Q38208182-8A64EC37-CB72-4FDE-8633-3B6DEE301D67Q38392123-34CFC7C8-ED7C-41A4-91EE-436476C50C06Q38856019-40E7BA40-9FFA-4645-B6BA-AADFCECCDBECQ38891823-622AF507-FB94-4C08-AB61-D6AF214BF0FBQ40047035-8B57AE00-F402-4B2A-9A99-3EFFD315B892Q40402965-CB6D348B-501D-4137-B4B2-92507E3C76C8Q40469741-AC8624ED-C006-479B-8812-24F893C09D99Q41551291-C2E2252D-273F-463A-9813-05762712FC9AQ42184292-839B638C-5110-4B03-BEC7-C326850F98B0Q42256619-0AF7BC18-1192-46B6-A6C8-07BDCAA1C960Q42378458-7D394203-8866-416D-8500-6EA69CA435D9Q47133389-BF3E01C5-6F28-4913-A1B0-1C507F60BF9AQ47241285-E865BB8A-F8AC-49AF-ACED-2F5ECE28E39AQ48105843-F8D8B05D-008F-4598-BD2F-A323967BA3B7Q48182512-30ADFE9D-F81E-4C2B-9154-C73E225A968AQ50098505-2D58E35D-F4D3-49CA-967B-24D459E5162EQ51099991-8CB01B02-EA87-4AC9-AA4C-5215072B702EQ51224059-B5AAE54C-71A9-47FF-B2C1-DF496F2795B9Q51557016-D7337998-7B83-4D59-9D15-3C531A6496D0Q55241910-5450F0EB-16E8-4632-8F09-48577BAD9672Q58726355-23A1BB0D-9B50-4073-826A-720F11E93EBD
P2860
Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Next-generation tissue microar ...... x different solid tumor types.
@en
type
label
Next-generation tissue microar ...... x different solid tumor types.
@en
prefLabel
Next-generation tissue microar ...... x different solid tumor types.
@en
P2093
P2860
P356
P1476
Next-generation tissue microar ...... x different solid tumor types.
@en
P2093
Alessandro Lugli
Heather Dawson
Inti Zlobec
P2860
P2888
P356
10.1186/1479-5876-11-104
P577
2013-04-30T00:00:00Z
P5875
P6179
1051498015